The role of the Aspergillus niger furin-type protease gene in processing of fungal proproteins and fusion proteins : Evidence for alternative processing of recombinant (fusion-) proteins

We have characterized growth and protein processing characteristics of Aspergillus niger strains carrying a disrupted allele of the previously cloned and characterized kexB gene [Appl. Environ. Microbiol. 66 (2000) 363] encoding a furin-type endoprotease. Deletion of the single-copy gene confirms it...

Full description

Saved in:
Bibliographic Details
Published in:Journal of biotechnology Vol. 106; no. 1; pp. 23 - 32
Main Authors: Punt, P.J, Drint-Kuijvenhoven, A, Lokman, B.C, Spencer, J.A, Jeenes, D, Archer, D.A, van den Hondel, C.A.M.J.J
Format: Journal Article
Language:English
Published: Lausanne Elsevier B.V 05-12-2003
Amsterdam Elsevier
New York, NY
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We have characterized growth and protein processing characteristics of Aspergillus niger strains carrying a disrupted allele of the previously cloned and characterized kexB gene [Appl. Environ. Microbiol. 66 (2000) 363] encoding a furin-type endoprotease. Deletion of the single-copy gene confirms it to be non-essential but disruptant strains exhibit a morphologically distinct phenotype characterized by hyperbranching. Processing of homologous pro-proteins and fusion proteins comprised of a heterologous protein fused down-stream of glucoamylase and separated at the fusion junction by an endoproteolytic cleavage site was compared in wildtype and mutant strains of A. niger. We show that maturation of the native glucoamylase requires KexB, whereas maturation of aspergillopepsin does not. The processing of fusion proteins carrying Lys–Arg requires KexB, although alternative endoproteases are capable of cleaving protein fusions at sites adjacent to Lys–Arg.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0168-1656
1873-4863
DOI:10.1016/j.jbiotec.2003.09.005